Alice Ticca
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Clinical correlates of a negative cerebrospinal fluid α-synuclein seed amplification assay result in Parkinson's disease.
Journal: NPJ Parkinson's disease
Published: December 15, 2025
Characterization of patients with isolated REM sleep behavior disorder and cerebrospinal fluid α-synuclein negativity.
Journal: NPJ Parkinson's disease
Published: December 12, 2025
Quantification of cerebrospinal fluid α-synuclein seeds by endpoint dilution seed amplification assay in Parkinson's disease.
Journal: NPJ Parkinson's disease
Published: August 28, 2025
Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum.
Journal: Brain : a journal of neurology
Published: August 19, 2024
MRI Signature of α-Synuclein Pathology in Asymptomatic Stages and a Memory Clinic Population.
Journal: JAMA neurology
Published: July 28, 2024
Clinical, neuropathological, and molecular characteristics of rapidly progressive dementia with Lewy bodies: a distinct clinicopathological entity?
Journal: Alzheimer's research & therapy
Published: June 10, 2024
CSF markers of neurodegeneration Alzheimer's and Lewy body pathology in isolated REM sleep behavior disorder.
Journal: NPJ Parkinson's disease
Published: March 04, 2024
Improving protocols for α-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantification.
Journal: Clinical chemistry and laboratory medicine
Published: December 19, 2023
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden.
Journal: Acta neuropathologica
Published: September 18, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026